Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
Deltex reaps benefit of NICE recommendation

Blood monitoring specialist Deltex Medical saw sales rise in the first half of this year thanks to growing market acceptance of its CardioQ-ODM product for managing surgery patients.

The Aim-listed firm saw overall sales cross the £3 million mark for the six months ended 30 June 2011, up by around £100,000 on the same period last year.

The company also announced that the increased adoption of CardioQ-ODM in the UK had generated over £400,000 in additional revenue, but that this was partly offset by a reduction in sales of monitors in the Middle East.

In March, the National Institute for Health and Clinical Excellence (NICE) published guidance to the NHS in England recommending CardioQ-ODM for use in almost all major and high risk surgery. Commenting on this development, Deltex said the company's UK success was dependent on “the rate of growth in surgical probe sales”. It added that “this has increased since the NICE recommendation”.

However, turning to its international ambitions, the firm pointed out that in the US, clinical awareness of optimising vascular fluids among surgery patients “remains some way behind the UK and continental Europe”.

It also said that as a result of uncertainties caused by political unrest in the Middle East, the company has redeployed some of its resources to other potential markets with developed healthcare systems, including Scandanavia, Canada and Australia. Deltex chairman Nigel Keen claimed the firm is well-positioned to roll-out the CardioQ-ODM “into a number of export markets”. 

Posted on: 18/07/2011

Latest news stories

Another mental health unit run by Cygnet Health Care is at the centre of allegations of poor care after the Care Quality Commission placed it into special measures.
Independent physiotherapy provider, Ascenti today announced a partnership with national health club operator The Bannatyne Group, under which Ascenti will operate across Bannatyne sites.
MPs have backed the removal of NHS compulsory competitive tendering service procurement rules.
The majority of care homes fail to provide adequate dental care and hygiene to residents, the Care Quality Commission claimed today.
Northwest-focused Praetura Ventures today announced it is backing fertility start-up Dr Fertility in a £1 million seed round.


HealthInvestor blog
As one of the UK’s largest care providers goes into administration, is it time to consider a more sustainable investment model to provide security for the country’s most vulnerable citizens?

Click here to view the HealthInvestor blog

Against the backdrop of a robust healthcare market with positive macro factors, speakers and delegates delved into the opportunities and challenges, and analysed the changing face of the region’s healthcare market
Athena Care Homes’ managing director is a daughter of immigrant parents who grew up in Basildon, Essex with her seven siblings, in a house where there was never a dull moment. That also meant her future was very much in her own hands
Medbelle is one of the best-rated medical providers in the UK. It is also a hospital without concrete walls – rather it is a ‘digital hospital’ offering self-pay elective procedures. Marie Cahalane goes on a digital journey with co-founder and managing director Leander de Laporte for a better understanding of how it works and its successes to date
As the Competition & Markets Authority prepares to launch a major investigation into the fragmented and largely unregulated funeral services sector, Rob Munro asks if the time is right for consolidation
As direct-to-consumer genetic testing gains popularity among millennials and early adopters, Rob Munro reviews the technology and considers the opportunities and potential pitfalls for investors

Click here to search all feature articles

Alantra Specialist Care Fast 50
According to global mid-market investment bank Alantra's latest report, the UK's specialist care market is growing and offers an attractive investment opportunity for those prepared to put quality at the top of the agenda. Justin Crowther, partner and head of healthcare at Alantra, gives an overview of the findings
Read more

Christie + Co

my images


As the Competition & Markets Authority prepares to launch a major investigation into the fragmented and largely unregulated funeral services sector, Rob Munro asks if the time is right for consolidation
Read more